Suppr超能文献

嗜铬细胞瘤患者中血管紧张素 II 阻断对高血压的部分纠正作用

Partial correction of hypertension by angiotensin II blockade in a patient with phaeochromocytoma.

作者信息

van Hoogdalem P, Donker A J, Brentjens J R, van der Hem G K, Oosterhuis J W

出版信息

Acta Med Scand. 1977;201(4):395-9. doi: 10.1111/j.0954-6820.1977.tb15719.x.

Abstract

This case report describes a patient with malignant hypertension and phaeochromocytoma in whom blockade of angiotensin II receptors by the competitive antagonist 1-sar-8-ala-angiotensin II (Saralasin) resulted in a partial correction of the elevated BP. Plasma renin activity was high and rose further during the blockade. Competitive inhibition of angiotensin II by Saralasin does not abolish the pressor effect of catecholamines. It was therefore interesting to observe that in this patient with phaeochromocytoma, independently, both alpha-adrenergic receptor blockade and angiotensin II receptor blockade were effective in lowering BP.

摘要

本病例报告描述了一名患有恶性高血压和嗜铬细胞瘤的患者,竞争性拮抗剂1-肌氨酸-8-丙氨酸血管紧张素II(沙拉新)对血管紧张素II受体的阻断导致血压升高得到部分纠正。血浆肾素活性较高,在阻断过程中进一步升高。沙拉新对血管紧张素II的竞争性抑制并不能消除儿茶酚胺的升压作用。因此,有趣的是观察到,在这名嗜铬细胞瘤患者中,单独使用α-肾上腺素能受体阻断和血管紧张素II受体阻断均能有效降低血压。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验